Author

Dickson Anumenden

Institution: Janssen (Belgium)

Observed institution: Janssen (Belgium)

OpenAlex ID: A5060414045

First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study

2022 · Viki Bockstal, Georgi Shukarev, et al. · PLoS ONE · 34

Works count: 1

Citation count: 34

H-index: 1

I10-index: 1